AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

ABCL-187 Phase 2 Response-Adapted Study of Ibrutinib With Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) for Secondary CNS Lymphoma

Jillian Simard,James D Phelan,Christopher Melani,Rahul Lakhotia,Stefania Pittaluga,Jagan R Muppidi,Michail S Lionakis,Cody Peer,Amynah Pradhan,Matthias Holdhoff,Lode J Swinnen,Kieron Dunleavy,Catherine Lai,Sami Ibrahimi,Michael Glantz,John A Butman, Kim Johnson,Seth M Steinberg,William D Figg,Elaine S Jaffe

Clinical Lymphoma, Myeloma & Leukemia（2023）

引用 0|浏览8
暂无评分
关键词
DLBCL,diffuse large B-cell lymphoma,high-grade B-cell lymphoma,targeted therapy,ibrutinib,chemotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要